The guideline on setting health-based exposure limits indicates that the carry over limit should generally be derived using the human HBEL.
However, in cases where there is concern relating to known susceptibility of a particular species (e.g. monensin in horses) the HBEL approach should take into ac knowledge of specific animal toxicity when evaluating products manufactured in shared facilities/equipment.